What is Spinal Kinetics?
Spinal Kinetics is a medical technology company that has developed Computerized Radiographic Mensuration Analysis (CRMA®), an advanced x-ray measurement technology. This proprietary system enables board-certified medical radiologists to accurately quantify abnormal intersegmental motion in the spine, a critical indicator of spinal instability often resulting from ligamentous injury. Unlike MRI, which is not designed for dynamic motion assessment, CRMA® specifically targets and measures excessive spinal motion, providing unbiased diagnostic insights. The company aims to make this advanced diagnostic service easily accessible to healthcare providers, offering a streamlined process for utilizing their expertise in assessing spinal ligament damage and instability, thereby addressing a significant market need driven by the prevalence of spine-related injuries contributing to chronic pain and disability.
How much funding has Spinal Kinetics raised?
Spinal Kinetics has raised a total of $40.4M across 3 funding rounds:
Unspecified
$5.3M
Private Equity
$33.8M
Debt
$1.3M
Unspecified (2009): $5.3M, investors not publicly disclosed
Private Equity (2014): $33.8M led by Lumira Capital, SV Life Sciences, De Novo Ventures, HLM Venture Partners, and BA Venture Partners
Debt (2016): $1.3M, investors not publicly disclosed
Key Investors in Spinal Kinetics
Lumira Capital
Lumira Capital is a venture capital firm that invests in innovative healthcare and life sciences companies, providing strategic capital and expertise to foster growth and market leadership.
SV Life Sciences
SV Health Investors is a specialist investment firm backing innovative health care and life science companies, partnering with founders and management to provide capital, sector expertise and active support from early growth through scale and value creation.
De Novo Ventures
De Novo Ventures is a venture capital firm focused on investing in and building companies within the healthcare sector, leveraging deep industry knowledge and strategic partnerships.
What's next for Spinal Kinetics?
The recent major strategic investment in Spinal Kinetics signals a pivotal moment for the company, likely enabling accelerated development and broader market penetration of its CRMA® technology. With a clear focus on enhancing diagnostic capabilities for spinal ligament injuries and instability, the company is well-positioned to capitalize on the substantial market demand for effective pain management solutions. Future growth will likely involve expanding partnerships with healthcare providers, further refining the CRMA® platform, and potentially exploring new applications for its unique measurement technology. This strategic financing is expected to fuel innovation and solidify Spinal Kinetics' role as a leader in advanced spinal diagnostics.
See full Spinal Kinetics company page
